HAMELN PHARMA GMBH
Closed at April 14th, 2023
Keywords
researchdevelopment worknatural sciencesengineeringtechnologymedicineagricultureinterdisciplinary research
Organization
- Operation time
- 1 year
- - Aug 9, 2022 to Apr 14, 2023
- Type
- Norwegian division of foreign business enterprise
- VAT registered
- No
- Number of employees
- 0
Last update: Apr 13, 2023
Management
Board
| Name | Role | Shares |
|---|---|---|
R Closed | Norwegian Representative for Foreign Entity | - |
JA | Contact Person | - |
H Closed | Information about the Company in the Home Country | - |
Others
| Name | Role | Shares |
|---|---|---|
R Closed | Accountant | - |
Last update: Apr 13, 2023
Ownership
No available data
Financials
in NOK
Summary
| Year |
|---|
Total operating income |
Annual Total Result |
Total assets |
Total liabilities |
Total equity |
P&L
| Year |
|---|
Total operating income |
Total operating costs |
Operating result |
Financial income/costs |
Profit before tax |
Total tax & extraordinary income/cost |
Annual Total Result |
Balance overview
| Year |
|---|
Total fixed assets |
Total current assets |
Total assets |
Short term debt |
Long term debt |
Total liabilities |
Contributed capital |
Retained earnings |
Total equity |
Total equity and liabilities |
Classification
21st company classification
BETA
Small company
Category
Type of organization
Norwegian division of foreign business enterprise
Standard industrial classification
M
Main industrial area
Professional, scientific and technical activities
72
Activity
Scientific research and development
72.1
Main industrial group
Research and experimental development on natural sciences and engineering
72.19
Industrial group
Other research and experimental development on natural sciences and engineering
72.190
Industrial group
Other research and experimental development on natural sciences and engineering